GlassScriptPhysician profile
Takara May Ragland
NPI 1184249146
$3,657.94
in general payments reported to CMS, 2019-2025
20 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $2,058 · 2023: $1,040 · 2024: $121 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094 · Travel and Lodging: $304 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.88 |
| Travel and Lodging | $304.07 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,225.62 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $802.93 | 2022 | |
| Silk Road Medical, INC. | $582.89 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $123.08 | 2025 | Gore Tag Thoracic Branch Endoprosthesis |
| Integra Lifesciences Corporation | $114.92 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Janssen Pharmaceuticals, INC | $107.08 | 2023-2024 | Xarelto |
| Medical Device Business Services, INC. | $98.00 | 2023 | |
| Abbott Laboratories | $94.65 | 2025 | Xact |
| Viz.Ai, INC. | $86.50 | 2022 | |
| Amgen INC. | $83.62 | 2022-2024 | Repatha |
| Biotissue Holdings INC. | $78.91 | 2023-2024 | |
| Edwards Lifesciences Corporation | $51.73 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, LTD. | $40.54 | 2021-2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $32.91 | 2025 | |
| Impulse Dynamics (USA) INC. | $31.08 | 2023 | Optimizer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26.12 | 2025 | Flowtriever |
| United Therapeutics Corporation | $24.60 | 2025 | Tyvaso |
| Angiodynamics, INC. | $22.04 | 2023 | Auryon Laser System 100-120 Vac |
| Scpharmaceuticals INC. | $17.49 | 2024 | |
| Convatec INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Takara Ragland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.